Novo Nordisk announces CEO transition as share price slips

fastcompany.com/91336177/novo-nordisk-announces-ceo-transition-as-share-price-slips

Novo Nordisk announced Friday that it would part ways with its longtime CEO, who steered the company into an unprecedented boom time for weight loss drugs.
The Ozempic maker’s chief executive Lars Fruergaard Jorgensen first joined the company as an economist in 1991. Jorgensen has…

This story appeared on fastcompany.com, 2025-05-16 19:10:00.
The Entire Business World on a Single Page. Free to Use →